For a company deeply tied to the highs and setbacks of Alzheimer’s drug research, yesterday’s market reaction to new trial data from Biogen Inc (NASDAQ:BIIB, XETRA:IDP) looked brutally familiar. After ...

Despite some wincing sound and production design, Yeon Sang-ho fails to deliver the highs of his best zombie projects.

An outbreak of the hantavirus on a cruise ship recently sparked a bit of a rally in the pharmaceutical and biotech industries ...

Moderna (MRNA) stock rose 4% on Monday, extending its 12% rally on Friday. What’s behind the move: The biotech is researching ...

As antisemitism rises again, Jewish history offers a proven blueprint for rebuilding economic strength, independence, and ...

The business of pet longevity is booming — driven, in part, by experimental treatments that might also have implications for ...

Kash Patel, the F.B.I. director, sparred with a senator at a budget hearing over his conduct, including whether he ordered ...

Dr Robert Sikorski shares his experience working with the FDA, saying its technical staff remain knowledgeable and dedicated despite recent changes.

There is a pattern to how Cathie Wood exits positions. It rarely happens in one move. It happens in layers, a little here, a ...

Yeon Sang-ho’s zombie virus thriller Colony has been pre-sold to more than 120 territories by South Korea’s Showbox ahead of ...

Any products containing marijuana that are approved by the U.S. Food and Drug Administration (FDA) or are subject to state ...